ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements with these filters
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare reported Q1 FY27 financial results. Total income grew 18% year-over-year to ₹128.2 Crore, reflecting steady operational performance.
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
GPT Healthcare Ltd reported revenue from operations of ₹126.2 Cr (+17.8% YoY) and net profit of ₹12.7 Cr (+64.9% YoY) for Q1 FY27.
GPT Healthcare Limited has scheduled a board meeting for August 3, 2026, to consider and approve the company's unaudited financial results for the first quarter.
GPT Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI regulations.
GPT Healthcare convened its 37th AGM for August 6, 2026. Key agendas include a Rs.1.50 final dividend declaration and director re-appointments.
GPT Healthcare Limited submitted its 37th Annual Report and AGM notice for FY 2025-26. The 37th Annual General Meeting is scheduled for August 6, 2026.
GPT Healthcare Limited filed its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report confirms full regulatory compliance with no adverse observations.
GPT Healthcare reported Q4 FY26 revenue of ₹128cr (+24% YoY) and EBITDA margin of 19.5%. FY26 revenue stood at ₹478.5cr with an 18.8% margin.
GPT Healthcare delivered strong FY26 results with 24% YoY revenue growth in Q4, driven by the Raipur hospital scale-up and improved utilization in mature facilities like Salt Lake.
GPT Healthcare re-appointed its cost and internal auditors alongside several independent directors. These leadership and oversight renewals ensure regulatory compliance and operational continuity.
GPT Healthcare reported a 15.14% annual revenue growth to ₹478.5 Crore for FY26. Operational highlights include Raipur hospital commencement and 800+ robotic surgeries performed.
GPT Healthcare reported FY26 revenue of ₹478.5 Cr (up 15.1% YoY) and PAT of ₹42.2 Cr. Growth is driven by stronger clinical mix and the new Raipur hospital.
GPT Healthcare recommended a ₹1.50 per share final dividend for FY 2025-26. The record date is July 30, 2026, pending shareholder approval at the upcoming AGM.
GPT Healthcare Ltd reported revenue from operations of ₹126.4 Cr (+24.7% YoY) and net profit of ₹14.6 Cr (+13.2% YoY) for Q4 FY26.
GPT Healthcare reported a ₹42.72 Crore annual profit and recommended a ₹1.50 per share final dividend. Results show steady performance for the fiscal year ended 2026.